{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:08:03Z","timestamp":1790262483429,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-026-04279-1","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:36:03Z","timestamp":1790260563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The effect of topical insulin in the treatment of isotretinoin-associated dry eye disease in patients with acne vulgaris"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8221-9817","authenticated-orcid":false,"given":"Mehmet","family":"Komur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Altinkaynak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caner","family":"Kutlugun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman","family":"Sayin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"issue":"1","key":"4279_CR1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.det.2011.09.001","volume":"30","author":"S Knutsen-Larson","year":"2012","unstructured":"Knutsen-Larson S, Dawson AL, Dunnick CA, Dellavalle RP (2012) Acne vulgaris: pathogenesis, treatment, and needs assessment. Dermatol Clin 30(1):99\u2013106. https:\/\/doi.org\/10.1016\/j.det.2011.09.001","journal-title":"Dermatol Clin"},{"issue":"3","key":"4279_CR2","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jaad.2006.05.048","volume":"55","author":"DR Bickers","year":"2004","unstructured":"Bickers DR, Lim HW, Margolis D, Weinstock MA, Goodman C, Faulkner E et al (2004) The burden of skin diseases: 2004. J Am Acad Dermatol 55(3):490\u2013500. https:\/\/doi.org\/10.1016\/j.jaad.2006.05.048","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"4279_CR3","doi-asserted-by":"publisher","first-page":"e14438","DOI":"10.1111\/dth.14438","volume":"34","author":"A Sadeghzadeh-Bazargan","year":"2021","unstructured":"Sadeghzadeh-Bazargan A, Ghassemi M, Goodarzi A, Roohaninasab M, Najar Nobari N, Behrangi E (2021) Systematic review of low-dose isotretinoin for treatment of acne vulgaris: focus on indication, dosage, regimen, efficacy, safety, satisfaction, and follow up, based on clinical studies. Dermatol Ther 34(1):e14438. https:\/\/doi.org\/10.1111\/dth.14438","journal-title":"Dermatol Ther"},{"issue":"8","key":"4279_CR4","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1080\/09546634.2017.1309349","volume":"28","author":"S Khalil","year":"2017","unstructured":"Khalil S, Bardawil T, Stephan C, Darwiche N, Abbas O, Kibbi AG et al (2017) Retinoids: a journey from the molecular structures and mechanisms of action to clinical uses in dermatology and adverse effects. J Dermatol Treat 28(8):684\u2013696. https:\/\/doi.org\/10.1080\/09546634.2017.1309349","journal-title":"J Dermatol Treat"},{"issue":"8","key":"4279_CR5","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1080\/17512433.2020.1796637","volume":"13","author":"E Bagatin","year":"2020","unstructured":"Bagatin E, Costa CS (2020) The use of isotretinoin for acne - an update on optimal dosing, surveillance, and adverse effects. Expert Rev Clin Pharmacol 13(8):885\u2013897. https:\/\/doi.org\/10.1080\/17512433.2020.1796637","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"5","key":"4279_CR6","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/ICO.0000000000002229","volume":"39","author":"R Karadag","year":"2020","unstructured":"Karadag R, Karadag AS, Ozlu E, Oguztuzun S, Simsek GG, Esmer O et al (2020) Effects of different doses of systemic isotretinoin on eyes: a histopathological and immunohistochemical study in rats. Cornea 39(5):621\u2013627. https:\/\/doi.org\/10.1097\/ICO.0000000000002229","journal-title":"Cornea"},{"issue":"10","key":"4279_CR7","doi-asserted-by":"publisher","first-page":"e46335","DOI":"10.7759\/cureus.46335","volume":"15","author":"A Korkoman","year":"2023","unstructured":"Korkoman A, Alamri A, Al Zomia AS, Korkoman S, Qahtani SH, Alshahrani YM et al (2023) Cross-sectional assessment of dermatologists\u2019 knowledge and attitude towards isotretinoin-related ocular side effects in Aseer, Saudi Arabia. Cureus 15(10):e46335. https:\/\/doi.org\/10.7759\/cureus.46335","journal-title":"Cureus"},{"issue":"2","key":"4279_CR8","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1080\/09546634.2020.1774041","volume":"33","author":"E D\u00fczg\u00fcn","year":"2022","unstructured":"D\u00fczg\u00fcn E, \u00d6zkur E (2022) The effect of oral isotretinoin therapy on meibomian gland morphology and dry eye tests. J Dermatol Treat 33(2):762\u2013768. https:\/\/doi.org\/10.1080\/09546634.2020.1774041","journal-title":"J Dermatol Treat"},{"issue":"2","key":"4279_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/15569527.2022.2077749","volume":"41","author":"N Acar Eser","year":"2022","unstructured":"Acar Eser N, Kocabeyo\u011flu S, Atakan N, Irkec M (2022) The effects of the systemic isotretinoin treatment on ocular surface and meibomian glands: a prospective longitudinal study. Cutan Ocul Toxicol 41(2):155\u2013161. https:\/\/doi.org\/10.1080\/15569527.2022.2077749","journal-title":"Cutan Ocul Toxicol"},{"issue":"2","key":"4279_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/15569527.2022.2050747","volume":"41","author":"KA Elubous","year":"2022","unstructured":"Elubous KA, Toubasi AA, Elubous A, Alryalat SA, Abous H (2022) Ocular manifestations of systemic isotretinoin in patients with acne: a systemic review and meta-analysis. Cutan Ocul Toxicol 41(2):113\u2013122. https:\/\/doi.org\/10.1080\/15569527.2022.2050747","journal-title":"Cutan Ocul Toxicol"},{"issue":"5","key":"4279_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3238\/arztebl.2015.0071","volume":"112","author":"EM Messmer","year":"2015","unstructured":"Messmer EM (2015) The pathophysiology, diagnosis, and treatment of dry eye disease. Dtsch Arztebl Int 112(5):71\u201381. https:\/\/doi.org\/10.3238\/arztebl.2015.0071","journal-title":"Dtsch Arztebl Int"},{"key":"4279_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.47363\/JORRR\/2024(5)164","volume":"31","author":"N AbuSeif","year":"2024","unstructured":"AbuSeif N, Rajab M (2024) Effect of isotretinoin treatment on tear-film status and ocular surface disease index score in patients with acne vulgaris. J Ophthalmol Res Rev Rep 31:1\u20135. https:\/\/doi.org\/10.47363\/JORRR\/2024(5)164","journal-title":"J Ophthalmol Res Rev Rep"},{"key":"4279_CR13","doi-asserted-by":"publisher","first-page":"959165","DOI":"10.3389\/fmed.2022.959165","volume":"9","author":"MC S\u00e1nchez-Gonz\u00e1lez","year":"2022","unstructured":"S\u00e1nchez-Gonz\u00e1lez MC, De-Hita-Cantalejo C, Mart\u00ednez-Lara C, S\u00e1nchez-Gonz\u00e1lez JM (2022) Oral isotretinoin for acne vulgaris side effects on the ocular surface: hyaluronic acid and galacto-xyloglucan as treatment for dry eye disease signs and symptoms. Front Med (Lausanne) 9:959165. https:\/\/doi.org\/10.3389\/fmed.2022.959165","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"4279_CR14","doi-asserted-by":"publisher","first-page":"264","DOI":"10.33791\/2222-4408-2024-4-264-271","volume":"26","author":"AS Kisele","year":"2024","unstructured":"Kisele AS, Maslova EV, Trubilin AV, Yavorovskaya AA, Chernukha VA (2024) Dry eye syndrome associated with meibomian gland dysfunction in the context of isotretinoin use: a clinical case. The EYE GLAZ 26(4):264\u2013272. https:\/\/doi.org\/10.33791\/2222-4408-2024-4-264-271","journal-title":"The EYE GLAZ"},{"key":"4279_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/biology13030144","author":"M Woronkowicz","year":"2024","unstructured":"Woronkowicz M, Roberts H, Skopi\u0144ski P (2024) The role of insulin-like growth factor (IGF) system in the corneal epithelium homeostasis-from limbal epithelial stem cells to therapeutic applications. Biology. https:\/\/doi.org\/10.3390\/biology13030144","journal-title":"Biology"},{"key":"4279_CR16","doi-asserted-by":"publisher","DOI":"10.5935\/0004-2749.20160031","author":"LT Malki","year":"2016","unstructured":"Malki LT, Dias AC, Jorge AG, M\u00f3dulo CM, Rocha EM (2016) Lacrimal gland primary acinar cell culture: the role of insulin. Arq Bras Oftalmol. https:\/\/doi.org\/10.5935\/0004-2749.20160031","journal-title":"Arq Bras Oftalmol"},{"key":"4279_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1449985","author":"X Yuan","year":"2024","unstructured":"Yuan X, Zhang Y, Wang S, Du Z (2024) Protective effects of insulin on dry eye syndrome via TLR4\/NF-\u03baB pathway: based on network pharmacology and in vitro experiments validation. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2024.1449985","journal-title":"Front Pharmacol"},{"issue":"5","key":"4279_CR18","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.survophthal.2024.04.003","volume":"69","author":"I Krolo","year":"2024","unstructured":"Krolo I, Behaegel J, Termote K, de Bruyn B, De Schepper M, Oellerich S et al (2024) The role of topical insulin in ocular surface restoration: a review. Surv Ophthalmol 69(5):805\u2013817. https:\/\/doi.org\/10.1016\/j.survophthal.2024.04.003","journal-title":"Surv Ophthalmol"},{"issue":"Suppl 1","key":"4279_CR19","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1097\/ICL.0000000000000623","volume":"46","author":"N Aniah Azmi","year":"2020","unstructured":"Aniah Azmi N, Bastion MLC (2020) Short-term results of trial of topical insulin for treatment of dry eyes in diabetics. Eye Contact Lens 46(Suppl 1):S25-32. https:\/\/doi.org\/10.1097\/ICL.0000000000000623","journal-title":"Eye Contact Lens"},{"issue":"3","key":"4279_CR20","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1177\/11206721231206790","volume":"34","author":"B Burgos-Blasco","year":"2024","unstructured":"Burgos-Blasco B, Diaz-Valle D, Rego-Lorca D, Perez-Garcia P, Puebla-Garcia V, Fernandez-Vigo JI et al (2024) Topical insulin, a novel corneal epithelial regeneration agent in dry eye disease. Eur J Ophthalmol 34(3):719\u2013725. https:\/\/doi.org\/10.1177\/11206721231206790","journal-title":"Eur J Ophthalmol"},{"issue":"3","key":"4279_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/vision9030054","volume":"9","author":"MM Marzola","year":"2025","unstructured":"Marzola MM, Gutierrez DR, Cintra BC, Murashima AdeAB, Dalmolin LF, Garcia DM et al (2025) Insulin nanoemulsion eye drops for the treatment of dry eye disease in Sj\u00f6gren\u2019s disease: a randomized clinical trial phase I\/II. Vision Res 9(3):54. https:\/\/doi.org\/10.3390\/vision9030054","journal-title":"Vision Res"},{"key":"4279_CR22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ajo.2025.05.039","volume":"279","author":"L Jones","year":"2025","unstructured":"Jones L, Craig JP, Markoulli M, Karpecki P, Akpek EK, Basu S et al (2025) TFOS DEWS III: management and therapy. Am J Ophthalmol 279:289\u2013386. https:\/\/doi.org\/10.1016\/j.ajo.2025.05.039","journal-title":"Am J Ophthalmol"},{"issue":"13","key":"4279_CR23","first-page":"408","volume":"48","author":"MT Irkec","year":"2007","unstructured":"Irkec MT (2007) Reliability and validity of turkish translation of the ocular surface disease index (OSDI) in dry eye syndrome. Invest Ophthalmol Vis Sci 48(13):408","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4279_CR24","doi-asserted-by":"publisher","unstructured":"Bievel Radulescu R, Ferrari S, Ponzin D. (2024) Topical insulin as a novel treatment for persistent epithelial defects and other ocular surface disorders: a systematic review. https:\/\/doi.org\/10.1101\/2024.10.25.24316042","DOI":"10.1101\/2024.10.25.24316042"},{"key":"4279_CR25","doi-asserted-by":"publisher","unstructured":"Diaz\u2010Valle D, Burgos\u2010Blasco B, Rego\u2010Lorca D, Puebla\u2010Garcia V, Perez\u2010Garcia P, Benitez\u2010del\u2010Castillo JM, et al. (2022) Comparison of the efficacy of topical insulin with autologous serum eye drops in persistent epithelial defects of the cornea. Acta Ophthalmol. 18;100(4). https:\/\/doi.org\/10.1111\/aos.14997","DOI":"10.1111\/aos.14997"},{"issue":"5","key":"4279_CR26","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3390\/pharmaceutics16050580","volume":"16","author":"M Vicario-de-la-Torre","year":"2024","unstructured":"Vicario-de-la-Torre M, Puebla-Garc\u00eda V, Yba\u00f1ez-Garc\u00eda L, L\u00f3pez-Cano JJ, Gonz\u00e1lez-Cela-Casamayor MA, Brugnera M et al (2024) Topical insulin eye drops: stability and safety of two compounded formulations for treating persistent corneal epithelial defects. Pharmaceutics 16(5):580. https:\/\/doi.org\/10.3390\/pharmaceutics16050580","journal-title":"Pharmaceutics"},{"issue":"12","key":"4279_CR27","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.1007\/s10792-023-02868-y","volume":"43","author":"M Lekskul","year":"2023","unstructured":"Lekskul M, Thaiwat S, Lekvijittada J (2023) Evaluation of recovery time of tear film function and ocular surface after discontinuing oral isotretinoin treatment for acne vulgaris\u202f: Correlation between oral isotretinoin and tear film function. Int Ophthalmol 43(12):4683\u20134688. https:\/\/doi.org\/10.1007\/s10792-023-02868-y","journal-title":"Int Ophthalmol"},{"key":"4279_CR28","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jtos.2023.08.006","volume":"30","author":"F March de Ribot","year":"2023","unstructured":"March de Ribot F, Benitez Del Castillo JM, Geerling G, Messmer EM, Baudouin C, Alves M (2023) Dry eye disease sustainability. Ocul Surf 30:104\u2013106. https:\/\/doi.org\/10.1016\/j.jtos.2023.08.006","journal-title":"Ocul Surf"},{"key":"4279_CR29","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jtos.2022.05.005","volume":"25","author":"G Govindasamy","year":"2022","unstructured":"Govindasamy G, Lim C, Riau AK, Tong L (2022) Limiting plastic waste in dry eye practice for environmental sustainability. Ocul Surf 25:87\u201388. https:\/\/doi.org\/10.1016\/j.jtos.2022.05.005","journal-title":"Ocul Surf"},{"issue":"1","key":"4279_CR30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4103\/djo.djo_59_23","volume":"25","author":"SM Mehrez","year":"2024","unstructured":"Mehrez SM, Ghoraba ME, Hasby HA, Khater MM (2024) Comparative study between topical insulin, autologous serum, and honey-based eye drops as adjunctive treatment in resistant corneal ulcer. Delta J Ophthalmol 25(1):7\u201313. https:\/\/doi.org\/10.4103\/djo.djo_59_23","journal-title":"Delta J Ophthalmol"},{"issue":"6","key":"4279_CR31","doi-asserted-by":"publisher","first-page":"e62065","DOI":"10.7759\/cureus.62065","volume":"16","author":"KA Moin","year":"2024","unstructured":"Moin KA, Pandiri S, Manion GN, Brown AH, Moshirfar M, Hoopes PC (2024) The utilization of topical insulin for ocular surface diseases: a narrative review. Cureus 16(6):e62065. https:\/\/doi.org\/10.7759\/cureus.62065","journal-title":"Cureus"},{"issue":"1","key":"4279_CR32","doi-asserted-by":"publisher","first-page":"4378","DOI":"10.1038\/s41598-018-21031-7","volume":"8","author":"R Titone","year":"2018","unstructured":"Titone R, Zhu M, Robertson DM (2018) Insulin mediates de novo nuclear accumulation of the IGF-1\/insulin hybrid receptor in corneal epithelial cells. Sci Rep 8(1):4378. https:\/\/doi.org\/10.1038\/s41598-018-21031-7","journal-title":"Sci Rep"},{"key":"4279_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2019.04.014","volume":"140","author":"ELC Cruz-Cazarim","year":"2019","unstructured":"Cruz-Cazarim ELC, Cazarim MS, Ogunjimi AT, Petrilli R, Rocha EM, Lopez RFV (2019) Prospective insulin-based ophthalmic delivery systems for the treatment of dry eye syndrome and corneal injuries. Eur J Pharm Biopharm 140:1\u201310. https:\/\/doi.org\/10.1016\/j.ejpb.2019.04.014","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"4279_CR34","first-page":"963","volume":"43","author":"EM Rocha","year":"2002","unstructured":"Rocha EM, Cunha DA, Carneiro EM, Boschero AC, Saad MJA, Velloso LA (2002) Identification of insulin in the tear film and insulin receptor and IGF-1 receptor on the human ocular surface. Invest Ophthalmol Vis Sci 43(4):963\u2013967","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"4279_CR35","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s12020-009-9208-9","volume":"36","author":"CM M\u00f3dulo","year":"2009","unstructured":"M\u00f3dulo CM, Jorge AG, Dias AC, Braz AM, Bertazolli-Filho R, Jord\u00e3o AA et al (2009) Influence of insulin treatment on the lacrimal gland and ocular surface of diabetic rats. Endocrine (Basingstoke) 36(1):161\u2013168. https:\/\/doi.org\/10.1007\/s12020-009-9208-9","journal-title":"Endocrine (Basingstoke)"},{"issue":"3","key":"4279_CR36","doi-asserted-by":"publisher","first-page":"158","DOI":"10.5935\/0004-2749.20150041","volume":"78","author":"AC Dias","year":"2015","unstructured":"Dias AC, Batista TM, Roma LP, M\u00f3dulo CM, Malki LT, Dias LC et al (2015) Insulin replacement restores the vesicular secretory apparatus in the diabetic rat lacrimal gland. Arq Bras Oftalmol 78(3):158\u2013163. https:\/\/doi.org\/10.5935\/0004-2749.20150041","journal-title":"Arq Bras Oftalmol"},{"issue":"6","key":"4279_CR37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1590\/S0004-27492008000700017","volume":"71","author":"C De Paiva","year":"2008","unstructured":"De Paiva C, Pflugfelder S (2008) Rationale for anti-inflammatory therapy in dry eye syndrome. Arq Bras Oftalmol 71(6):89\u201395. https:\/\/doi.org\/10.1590\/S0004-27492008000700017","journal-title":"Arq Bras Oftalmol"},{"issue":"1","key":"4279_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.clae.2010.08.007","volume":"34","author":"M Tavakoli","year":"2011","unstructured":"Tavakoli M, Boulton AJM, Efron N, Malik RA (2011) Increased Langerhan cell density and corneal nerve damage in diabetic patients: role of immune mechanisms in human diabetic neuropathy. Contact Lens Anterior Eye 34(1):7\u201311. https:\/\/doi.org\/10.1016\/j.clae.2010.08.007","journal-title":"Contact Lens Anterior Eye"},{"issue":"2","key":"4279_CR39","doi-asserted-by":"publisher","first-page":"102346","DOI":"10.1016\/j.clae.2024.102346","volume":"48","author":"A Atikah","year":"2025","unstructured":"Atikah A, Suzana M, Wan Haslina WAH, Norshamsiah MD, Mushawiahti M, Birinder KSS et al (2025) Randomised controlled trial on effects of topical insulin compared to artificial tears and normal saline on tear inflammatory mediator levels and clinical parameters in diabetics with dry eye disease. Contact Lens Anterior Eye 48(2):102346. https:\/\/doi.org\/10.1016\/j.clae.2024.102346","journal-title":"Contact Lens Anterior Eye"},{"issue":"1","key":"4279_CR40","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10792-016-0263-y","volume":"37","author":"C Caglar","year":"2017","unstructured":"Caglar C, Senel E, Sabancilar E, Durmus M (2017) Reduced ocular surface disease index (OSDI) scores in patients with isotretinoin treatment. Int Ophthalmol 37(1):197\u2013202. https:\/\/doi.org\/10.1007\/s10792-016-0263-y","journal-title":"Int Ophthalmol"},{"issue":"1","key":"4279_CR41","first-page":"43","volume":"40","author":"MM Jumblatt","year":"1999","unstructured":"Jumblatt MM, McKenzie RW, Jumblatt JE (1999) MUC5AC mucin is a component of the human precorneal tear film. Invest Ophthalmol Vis Sci 40(1):43\u201349","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4279_CR42","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1097\/00003226-200203001-00005","volume":"21","author":"H Watanabe","year":"2002","unstructured":"Watanabe H (2002) Significance of mucin on the ocular surface. Cornea 21:S17-22. https:\/\/doi.org\/10.1097\/00003226-200203001-00005","journal-title":"Cornea"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04279-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-026-04279-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-026-04279-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:36:04Z","timestamp":1790260564000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-026-04279-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4279"],"URL":"https:\/\/doi.org\/10.1007\/s10792-026-04279-1","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"assertion":[{"value":"10 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Ethics Committee of Konya City Hospital (March 9, 2026; decision no: 2026\/57) and was conducted in accordance with the tenets of the Declaration of Helsinki. The requirement for informed consent was waived due to the retrospective nature of the study.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"403"}}